Satellos Bioscience Inc. (MSCLF)
USD 0.48
(-4.42%)
USD 0.48
(-4.42%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -15.46 Million CAD | -83.94% |
| 2022 | -8.4 Million CAD | -77.48% |
| 2021 | -4.73 Million CAD | -206.54% |
| 2020 | -1.54 Million CAD | 29.94% |
| 2019 | -2.2 Million CAD | -0.18% |
| 2018 | -2.2 Million CAD | -49.44% |
| 2017 | -1.47 Million CAD | -19.68% |
| 2016 | -1.23 Million CAD | 44.34% |
| 2015 | -2.21 Million CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -8.25 Million CAD | -32.12% |
| 2024 Q2 | -6.32 Million CAD | 19.09% |
| 2023 Q2 | -2.81 Million CAD | -69.46% |
| 2023 FY | -15.46 Million CAD | -83.94% |
| 2023 Q3 | -4.48 Million CAD | -59.67% |
| 2023 Q1 | -1.65 Million CAD | 26.06% |
| 2023 Q4 | -6.24 Million CAD | -39.22% |
| 2022 Q1 | -2.11 Million CAD | -38.04% |
| 2022 FY | -8.4 Million CAD | -77.48% |
| 2022 Q4 | -2.24 Million CAD | -22.18% |
| 2022 Q3 | -1.83 Million CAD | 16.88% |
| 2022 Q2 | -2.2 Million CAD | -4.26% |
| 2021 Q3 | -1.52 Million CAD | -201.24% |
| 2021 Q1 | -856.41 Thousand CAD | -60.27% |
| 2021 Q2 | -505.12 Thousand CAD | 41.02% |
| 2021 FY | -4.73 Million CAD | -206.54% |
| 2021 Q4 | -1.53 Million CAD | -0.86% |
| 2020 Q4 | -534.36 Thousand CAD | -81.49% |
| 2020 Q3 | -294.42 Thousand CAD | 9.96% |
| 2020 Q2 | -326.99 Thousand CAD | 48.33% |
| 2020 Q1 | -632.86 Thousand CAD | 0.0% |
| 2020 FY | -1.54 Million CAD | 29.94% |
| 2019 FY | -2.2 Million CAD | -0.18% |
| 2018 FY | -2.2 Million CAD | -49.44% |
| 2017 FY | -1.47 Million CAD | -19.68% |
| 2016 FY | -1.23 Million CAD | 44.34% |
| 2015 FY | -2.21 Million CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Evofem Biosciences, Inc. | -17.84 Million USD | 13.358% |
| Arch Therapeutics, Inc. | -5.04 Million USD | -206.533% |
| CSL Limited | 3.7 Billion USD | 100.418% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 118.891% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -2150.964% |
| BioStem Technologies, Inc. | -7.77 Million USD | -98.78% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -1131.131% |
| Qrons Inc. | -643.67 Thousand USD | -2302.292% |
| Nascent Biotech, Inc. | -2.22 Million USD | -593.446% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 72.143% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | -132.596% |
| Skye Bioscience, Inc. | -13.67 Million USD | -13.101% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -3621.728% |
| Rebus Holdings, Inc. | -664 Thousand USD | -2228.765% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 2.563% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -1057.903% |
| Genscript Biotech Corporation | -415.79 Million USD | 96.281% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -3869.248% |
| Adynxx, Inc. | - USD | Infinity% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 78.46% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 414.62% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -5808.087% |
| SQZ Biotechnologies Company | -75.82 Million USD | 79.607% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -442.465% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -906.674% |
| Mesoblast Limited | -84.14 Million USD | 81.624% |
| Marizyme, Inc. | -34.08 Million USD | 54.636% |
| Genus plc | 6.4 Million USD | 341.609% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 258.718% |
| Pharming Group N.V. | -4.87 Million USD | -216.894% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -678.412% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -1560.225% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | -85.186% |
| ContraFect Corporation | -56.88 Million USD | 72.819% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | -239.494% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -1002.931% |
| IMV Inc. | -38.67 Million USD | 60.014% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -462.119% |
| MultiCell Technologies, Inc. | -722.81 USD | -2139189.717% |
| ONE Bio Corp. | 13.68 Million USD | 213.021% |
| Accustem Sciences Inc. | -3.74 Million USD | -312.741% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 73.787% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -483.06 Thousand USD | -3101.038% |
| Q BioMed Inc. | -3.44 Million USD | -348.773% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 536.808% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -488.501% |
| Biomind Labs Inc. | -1 Million USD | -1431.592% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 71.871% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -432.977% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -729.395% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -51525.935% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -700.11% |
| GB Sciences, Inc. | -1.42 Million USD | -988.553% |
| Alpha Cognition Inc. | -9.7 Million USD | -59.32% |
| HST Global, Inc. | -140.9 Thousand USD | -10873.905% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -1274.604% |
| Halberd Corporation | -75.05 Thousand USD | -20503.598% |
| Enzolytics Inc. | -2.14 Million USD | -619.611% |
| Agentix Corp. | -1.37 Million USD | -1027.241% |
| Resverlogix Corp. | -12.74 Million USD | -21.288% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | -388.058% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -425.04 Million USD | 96.362% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -1381.13% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -429.656% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -879.071% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | -354.129% |
| AVAX Technologies, Inc. | 6.69 Million USD | 331.037% |
| Zenith Capital Corp. | -8.94 Million USD | -72.906% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -88660.691% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -529.776% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -8915.825% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -671.315% |
| Kadimastem Ltd | -3.04 Million USD | -408.609% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -1471.358% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -8420.263% |
| LadRx Corporation | -3.82 Million USD | -304.407% |
| Cell Source, Inc. | -4.32 Million USD | -257.497% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -2150.964% |
| NovAccess Global Inc. | -2.46 Million USD | -526.855% |
| Affymax, Inc. | -15.04 Million USD | -2.772% |
| Itoco Inc. | -919.14 Thousand USD | -1582.333% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | -264.83% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -1281.859% |
| Mobile Lads Corp. | -554.55 Thousand USD | -2688.387% |
| CytoDyn Inc. | -18.05 Million USD | 14.37% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -61334.247% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -6926.145% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -2638.157% |
| SYBLEU INC | -149.18 Thousand USD | -10265.33% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -751.337% |
| International Stem Cell Corporation | -663 Thousand USD | -2232.278% |
| Bioxytran, Inc. | -3.82 Million USD | -304.775% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -29275.0% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -75922.616% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 57.362% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -855.686% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -2001.422% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | -397.043% |
| Neutra Corp. | -229.48 Thousand USD | -6638.102% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | 11.836% |
| PureTech Health plc | -146.19 Million USD | 89.423% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | 28.049% |
| IXICO plc | -1.43 Million USD | -976.061% |
| IntelGenx Technologies Corp. | -9.49 Million USD | -62.923% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 87.305% |
| CSL Limited | 3.81 Billion USD | 100.406% |
| Cellectis S.A. | -108.85 Million USD | 85.795% |